Southern Capital Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
ECSS
Southern Capital Advisors's MRK Position: Q2 2026 in Review
Southern Capital Advisors increased its Merck (MRK) stake by 0.13% in Q2 2026, buying an estimated $936 and bringing the position to 5,961 shares worth $766K. The position accounts for 0.32% of the portfolio, ranked #30.
Southern Capital Advisors first reported a position in MRK in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.2M in Q2 2023. 1,865 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Southern Capital Advisors held 5,961 shares of Merck worth $766K as of Q2 2026.
- Southern Capital Advisors bought 8 Merck shares in Q2 2026, an estimated $936.
- Merck made up 0.32% of Southern Capital Advisors's portfolio in Q2 2026, its #30 holding.
- Southern Capital Advisors first reported a position in Merck in Q4 2021 and has held it in 19 quarters since.
- Southern Capital Advisors's Merck position peaked at $2.2M in Q2 2023.
- 1,865 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Southern Capital Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.